Literature DB >> 26897066

Dematiaceous Molds.

Eunice H Wong1, Sanjay G Revankar2.   

Abstract

Dematiaceous fungi are the cause of phaeohyphomycosis, a term that encompasses many clinical syndromes, from local infections due to trauma to widely disseminated infection in immunocompromised patients. These fungi are unique owing to the presence of melanin in their cell walls, which imparts the characteristic dark color to their spores and hyphae. Melanin may also be a virulence factor. Local infection may be cured with excision alone, whereas systemic disease is often refractory to therapy. Azoles have the most consistent in vitro activity. Further studies are needed to better understand the pathogenesis and treatment of these uncommon infections.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amphotericin B; Dematiaceous; Isavuconazole; Itraconazole; Phaeohyphomycosis; Posaconazole; Voriconazole

Mesh:

Substances:

Year:  2016        PMID: 26897066     DOI: 10.1016/j.idc.2015.10.007

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  7 in total

1.  In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared with Those of Five Antifungal Drugs against Melanized Fungi and Relatives.

Authors:  Gholam Reza Shokoohi; Hamid Badali; Hossein Mirhendi; Saham Ansari; Ali Rezaei-Matehkolaei; Bahram Ahmadi; Afsane Vaezi; Mohamed Mahdi Alshahni; Koichi Makimura
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

2.  In Vitro Activities of Ravuconazole and Isavuconazole against Dematiaceous Fungi.

Authors:  Hailin Zheng; Nana Song; Huan Mei; Jiacheng Dong; Dongmei Li; Xiaofang Li; Weida Liu
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

3.  Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.

Authors:  Sheena Mukkada; Jeannette Kirby; Nopporn Apiwattanakul; Randall T Hayden; Miguela A Caniza
Journal:  Curr Clin Microbiol Rep       Date:  2016-04-18

4.  Isolation and molecular characterization of clinical and environmental dematiaceous fungi and relatives from Iran.

Authors:  Gholamreza Shokoohi; Hamid Badali; Bahram Ahmadi; Kazuo Satoh; Sadegh Nouripour-Sisakht; Mahnaz Nikaeen; Mohsen Gramishoar; Nilufar Jalalizand; Sahar Kianipour; Hossein Mirhendi; Koichi Makimura
Journal:  Curr Med Mycol       Date:  2021-09

Review 5.  Rare fungal infectious agents: a lurking enemy.

Authors:  Anna Skiada; Ioannis Pavleas; Maria Drogari-Apiranthitou
Journal:  F1000Res       Date:  2017-10-31

6.  A 53-Year-Old Male with Relapsed Diffuse Large B-Cell Lymphoma on Chemotherapy with a New Leg Lesion.

Authors:  Connie R Shi; Sarah N Robinson; Avery LaChance; Martin C Mihm; Daniela Kroshinsky
Journal:  Dermatopathology (Basel)       Date:  2017-11-16

7.  A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases.

Authors:  Sanjay G Revankar; John W Baddley; Sharon C-A Chen; Carol A Kauffman; Monica Slavin; Jose A Vazquez; Carlos Seas; Michele I Morris; M Hong Nguyen; Shmuel Shoham; George R Thompson; Barbara D Alexander; Jacques Simkins; Luis Ostrosky-Zeichner; Kathleen Mullane; George Alangaden; David R Andes; Oliver A Cornely; Kerstin Wahlers; Shawn R Lockhart; Peter G Pappas
Journal:  Open Forum Infect Dis       Date:  2017-09-26       Impact factor: 3.835

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.